mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.2 |
mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
-0.24 |
0.2 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.077 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.059 |
0.2 |